{"transactions":[{"id":741727,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:16.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":6.61,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0001193125-26-267496","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526267496/ownership.xml","form_type":"4"}},{"id":813412,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-07T23:09:14.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":30782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest as to 1/12 of the total award quarterly on the first calendar day of each July, October, January, and April, with the first tranche vesting on July 1, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":30782,"derivative":{"exercise_price":32.79,"expiration_date":"2036-04-02","underlying":"Common Stock","underlying_shares":30782},"source":{"system":"sec-edgar","filing":"0001849236-26-000004","document":"form4-04072026_110410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000184923626000004/form4-04072026_110410.xml","form_type":"4"}},{"id":1111735,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-13T20:25:29.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":77500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":77500,"derivative":{"exercise_price":4.58,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":77500},"source":{"system":"sec-edgar","filing":"0000950170-25-086236","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025086236/ownership.xml","form_type":"4"}},{"id":1207811,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T20:05:03.000Z","date":"2025-03-11","kind":"purchase","planned":false,"acquired":true,"shares":1860,"price":5.3357,"value":9924.402,"ownership":{"direct":true},"balance_after":2960,"source":{"system":"sec-edgar","filing":"0000950170-25-038706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017025038706/ownership.xml","form_type":"4"}},{"id":1480766,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-13T20:06:45.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":34400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":34400,"derivative":{"exercise_price":7.51,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":34400},"source":{"system":"sec-edgar","filing":"0000950170-24-072996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024072996/ownership.xml","form_type":"4"}},{"id":1483492,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T18:15:59.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":7.6742,"value":8441.62,"ownership":{"direct":true},"balance_after":1100,"source":{"system":"sec-edgar","filing":"0000950170-24-071765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000095017024071765/ownership.xml","form_type":"4"}},{"id":1862425,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-09T01:22:59.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":9650,"derivative":{"exercise_price":6.37,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0000899243-23-015007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924323015007/doc4.xml","form_type":"4"}},{"id":2085163,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-12-15T23:10:37.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":9650,"derivative":{"exercise_price":6.47,"expiration_date":"2032-12-13","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0000899243-22-038686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924322038686/doc4.xml","form_type":"4"}},{"id":2237812,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:10:22.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 7, 2022 and vests in equal quarterly installments over the 12 month period following the grant date, subject to continued service as a director or consultant."}],"balance_after":40000,"derivative":{"exercise_price":0.625,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-035457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122035457/doc4.xml","form_type":"4"}},{"id":2237811,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-09T21:10:22.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 7, 2022 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":51000,"derivative":{"exercise_price":0.625,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001209191-22-035457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919122035457/doc4.xml","form_type":"4"}},{"id":2809020,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T22:37:28.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 2, 2021 and vests in three equal annual installments on the anniversary of the grant date, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the option will accelerate in full."}],"balance_after":40000,"derivative":{"exercise_price":10.72,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-017929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919121017929/doc4.xml","form_type":"4"}}]}